ClinicalTrials.Veeva

Menu

Antitussive Effect of a Naturally Flavored Syrup Containing Diphenhydramine, Compared With Dextromethorphan and Placebo

Montefiore Medicine Academic Health System logo

Montefiore Medicine Academic Health System

Status and phase

Completed
Phase 4

Conditions

Cough Reflex Sensitivity

Treatments

Drug: diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo
Drug: diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan
Drug: placebo; dextromethorphan; diphenhydramine/phenylephrine/cocoa
Drug: placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan
Drug: dextromethorphan; diphenhydramine/phenylephrine/cocoa; placebo
Drug: dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa

Study type

Interventional

Funder types

Other

Identifiers

NCT02062710
MMC-IRB-13-10-170

Details and patient eligibility

About

The purpose of this study is to evaluate the antitussive (cough-suppressing) effects of two liquid medications: a combination of diphenhydramine and phenylephrine in a naturally cocoa flavoring, and, dextromethorphan syrup, compared with placebo.

Enrollment

22 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • healthy adult nonsmokers
  • onset of acute, viral upper respiratory tract infection (common cold) within 72 hours of enrollment

Exclusion criteria

  • smokers
  • history of asthma or other respiratory disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

22 participants in 6 patient groups

A, B, then C
Experimental group
Description:
Subjects received the following: Period 1: single oral dose of diphenhydramine 25 mg and phenylephrine 10 mg, in naturally-flavored cocoa syrup (treatment A). Period 2: dextromethorphan syrup 30 mg (treatment B); Period 3: placebo liquid, dextrose in water, 20 mL (treatment C). Intervention: capsaicin cough challenge testing 2 hours after study drug ingestion.Each dosing period separated by 1-2 day washout period.
Treatment:
Drug: dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan
Drug: placebo; dextromethorphan; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo
Drug: placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan
Drug: dextromethorphan; diphenhydramine/phenylephrine/cocoa; placebo
A, C, then B
Experimental group
Description:
Subjects received the following: Period 1: single oral doce of diphenhydramine 25 mg and phenylephrine 10 mg, in naturally-flavored cocoa syrup (treatment A); Period 2: placebo liquid, dextrose in watwer, 20 mL (treatment C); Period 3: dextromethorphan syrup 30 mg (treatment B). Intervention: capsaicin cough challenge testing 2 hours after study drug ingestion.Each dosing period separated by 1-2 day washout period.
Treatment:
Drug: dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan
Drug: placebo; dextromethorphan; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo
Drug: placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan
Drug: dextromethorphan; diphenhydramine/phenylephrine/cocoa; placebo
B, A, then C
Experimental group
Description:
Subjects received the following: Period 1: dextromethorphan syrup 30 mg (treatment B); Period 2: single dose of oral diphenhydramine 25 mg and phenylephrine 10 mg, in a naturally-flavored cocoa syrup (treatment A); Period 3: placebo liquid, dextrose in water, 20 mL (treatment C). Intervention: capsaicin cough challenge testing 2 hours after study drug ingestion. Each dosing period separated by 1-2 day washout period.
Treatment:
Drug: dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan
Drug: placebo; dextromethorphan; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo
Drug: placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan
Drug: dextromethorphan; diphenhydramine/phenylephrine/cocoa; placebo
B, C, then A
Experimental group
Description:
Subjects received the following: Period 1: dextromethorphan 30 mg syrup (treatment B); Period 2: placebo liquid, dextrose in water, 20 mL (treatment C); Period 3: single dose of oral diphenhydramine 25 mg and phenylephrine 10 mg in a naturally-flavored cocoa syrup (treatment A). Intervention: capsaicin cough challenge testing 2 hours after study drug ingestion. Each dosing period separated by 1-2 day washout period.
Treatment:
Drug: dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan
Drug: placebo; dextromethorphan; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo
Drug: placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan
Drug: dextromethorphan; diphenhydramine/phenylephrine/cocoa; placebo
C, A, then B
Experimental group
Description:
Subjects received the following: Period 1: placebo liquid, dextrose in water, 20 mL (treatment C); Period 2: a single oral dose of diphenhydramine 25 mg and phenylephrine 10 mg in a naturally-flavored cocoa syrup (treatment A); Period 3: dextromethorphan 30 mg syrup (treatment B). Intervention: capsaicin cough challenge testing 2 hours after study drug ingestion. Each dosing period separated by 1-2 day washout period.
Treatment:
Drug: dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan
Drug: placebo; dextromethorphan; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo
Drug: placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan
Drug: dextromethorphan; diphenhydramine/phenylephrine/cocoa; placebo
C, B, then A
Experimental group
Description:
Subjects received the following: Period 1: placebo liquid, dextrose in water, 20 mL (treatment C); Period 2: dextromethorphan 30 mg syrup (treatment B); Period 3: a single oral dose of diphenhydramine 25 mg and phenylephrine 10 mg in a naturally-flavored cocoa syrup (treatment A). Intervention: capsaicin cough challenge testing 2 hours after study drug ingestion. Each dosing period separated by 1-2 day washout period.
Treatment:
Drug: dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan
Drug: placebo; dextromethorphan; diphenhydramine/phenylephrine/cocoa
Drug: diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo
Drug: placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan
Drug: dextromethorphan; diphenhydramine/phenylephrine/cocoa; placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems